Selincro
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Nalmefene (Selincro®), an opioid receptor modulator, is approved in Japan, the European Union, and other countries for reducing…
L’alcool correspond au terme utilise pour designer l’ethanol. Si le produit est connu pour ses proprietes desinfectantes, a un…
Die 51-jährige Patientin nahm erstmalig Nalmefen (Selincro®) vor Besuch eines Festes ein. Eine Viertelstunde nach der Einnahme…
AIMS
To characterize a contemporaneous cohort of UK general practice patients with alcohol use disorder and describe their…
Nalmefene (Selincro) has been recommended to help people reduce their dependence on alcohol, in final draft guidance from the…
Nalmefene (Selincro) is the first drug approved for the reduction of alcohol consumption. In our New products review, Steve…
The opioid system modulator nalmefene (Selincro®) is the first pharmacological therapy to be approved in the EU to reduce alcohol…